Silence Therapeutics (SLN) Current Leases: 2019-2025
Historic Current Leases for Silence Therapeutics (SLN) over the last 4 years, with Sep 2025 value amounting to $85,000.
- Silence Therapeutics' Current Leases rose 147.06% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $85,000, marking a year-over-year increase of 147.06%. This contributed to the annual value of $117,000 for FY2024, which is 48.68% down from last year.
- Latest data reveals that Silence Therapeutics reported Current Leases of $85,000 as of Q3 2025, which was up 41.67% from $60,000 recorded in Q1 2025.
- Over the past 5 years, Silence Therapeutics' Current Leases peaked at $523,126 during Q4 2022, and registered a low of -$588,096 during Q3 2022.
- Over the past 3 years, Silence Therapeutics' median Current Leases value was -$206,426 (recorded in 2024), while the average stood at -$92,361.
- As far as peak fluctuations go, Silence Therapeutics' Current Leases plummeted by 1,243.29% in 2021, and later soared by 183.26% in 2022.
- Over the past 5 years, Silence Therapeutics' Current Leases (Quarterly) stood at $184,677 in 2021, then skyrocketed by 183.26% to $523,126 in 2022, then crashed by 56.42% to $228,000 in 2023, then tumbled by 48.68% to $117,000 in 2024, then skyrocketed by 147.06% to $85,000 in 2025.
- Its last three reported values are $85,000 in Q3 2025, $60,000 for Q1 2025, and $117,000 during Q4 2024.